The Secretary of the Biotechnology Development Headquarters of the Vice Presidency for Science and Technology outlined the plans of this headquarters to reduce the country's dependence on imports of strategic products, stating: "With investment in the domestic production of products such as plasma, insulin, and pneumococcal vaccines, a plan has been made to reduce approximately $300 million from the country's currency consumption."
Reduction of $300 Million in Currency Consumption with Biotechnology Products/Investment of 5 Trillion Rials in This Area
The Iranian Biotechnology Development Headquarters is implementing plans to reduce reliance on imports of strategic products by investing in domestic production. This initiative aims to save around $300 million in foreign currency by producing essential medical products like plasma, insulin, and vaccines.
👥 Key Players
📰 What Happened
The Iranian Biotechnology Development Headquarters announced plans to invest in domestic production of key medical products to reduce reliance on imports. This initiative aims to save approximately $300 million in foreign currency.
- Investment of 5 trillion rials in biotechnology products.
- Focus on producing plasma, insulin, and pneumococcal vaccines.
💡 Why It Matters
📚 Background
Iran has faced significant economic challenges due to international sanctions, prompting a push for self-sufficiency in various sectors, including healthcare.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%